Legal & General Group’s NovaBridge Biosciences American Depositary Shares NBP Stock Holding History

Legal & General Group’s Portfolio NBP Stock Details NBP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-1,191	Closed	-$1.01K	–	3378
2024 Q4	$1.01K	Hold	1,191	–	–	﹤0.01%	3387
2024 Q3	$1.47K	Hold	1,191	–	–	﹤0.01%	3400
2024 Q2	$1.99K	Hold	1,191	–	–	﹤0.01%	3405
2024 Q1	$2.22K	Hold	1,191	–	–	﹤0.01%	3345
2023 Q4	$2.26K	Hold	1,191	–	–	﹤0.01%	3364
2023 Q3	$1.57K	Sell	1,191 -5,068	-81%	-$11.1K	﹤0.01%	3406
2023 Q2	$18.7K	Hold	6,259	–	–	﹤0.01%	3134
2023 Q1	$21.7K	Hold	6,259	–	–	﹤0.01%	3046
2022 Q4	$26.2K	Hold	6,259	–	–	﹤0.01%	3096
2022 Q3	$25K	Sell	6,259 -151,173	-96%	-$1.15M	﹤0.01%	3150
2022 Q2	$1.78M	Sell	157,432 -91,255	-37%	-$1.09M	﹤0.01%	1949
2022 Q1	$4.04M	Buy	248,687 +21,071	+9%	+$540K	﹤0.01%	1640
2021 Q4	$10.8M	Buy	227,616 +72,332	+47%	+$4.34M	﹤0.01%	1169
2021 Q3	$11.3M	Buy	155,284 +49,251	+46%	+$3.56M	﹤0.01%	1111
2021 Q2	$8.9M	Buy	+106,033	New	+$7M	﹤0.01%	1232

Other funds holding NBP

HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return

SG Americas Securities New York $92.9B AUM 36.98% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

AIMCA

Alberta Investment Management Corp (AIMCo) Edmonton, Alberta, Canada $16.7B AUM 23.27% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Legal & General Group's NBP Position: Q1 2025 in Review

Legal & General Group sold out of NovaBridge Biosciences American Depositary Shares (NBP) in Q1 2025, closing a stake of 1,191 shares — an estimated $1.01K sold.

Legal & General Group first reported a position in NBP in Q2 2021 and held it in 15 quarters. The position peaked at $11.3M in Q3 2021. 29 funds tracked by Wall St. Rank hold NBP as of Q1 2025.

Legal & General Group reported no remaining NovaBridge Biosciences American Depositary Shares position as of Q1 2025 after selling out during the quarter.
Legal & General Group sold 1,191 NovaBridge Biosciences American Depositary Shares shares in Q1 2025, an estimated $1.01K.
Legal & General Group first reported a position in NovaBridge Biosciences American Depositary Shares in Q2 2021 and held it in 15 quarters.
Legal & General Group's NovaBridge Biosciences American Depositary Shares position peaked at $11.3M in Q3 2021.
29 funds tracked by Wall St. Rank held NovaBridge Biosciences American Depositary Shares as of Q1 2025.

Based on Legal & General Group's 13F filing for Q1 2025, filed 15 May 2025.